Innovative Spinopelvic Solutions With Real-World Evidence
INSPIRE
1 other identifier
observational
1,000
1 country
1
Brief Summary
INSPIRE is a prospective decentralized study evaluating post-operative health outcomes in patients who undergo a procedure using implants manufactured by SI-BONE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2024
CompletedFirst Posted
Study publicly available on registry
November 27, 2024
CompletedStudy Start
First participant enrolled
December 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2034
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2034
April 24, 2026
April 1, 2026
10 years
November 22, 2024
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in patient reported outcomes
Change in pain as rated on a numerical rating scale (NRS), 0 being no pain and 10 being the worst pain imaginable at baseline and follow-up timepoints.
From enrollment and at the following timepoints, 1-, 3-, 6-, and 12-months.
Secondary Outcomes (1)
Change in patient reported outcomes
At the following timepoints: 1-, 3-, 6-, and 12-months.
Other Outcomes (1)
Postoperative incidence of:
At the following timepoints, 1-, 3-, 6-, and 12-months.
Interventions
Participants are expected to complete a series of health questionnaires (i.e. numerical rating scale, Oswestry Disability Index) relevant to their treatment using a SI-BONE implant.
Eligibility Criteria
Patients treated with an implant manufactured by SI-BONE.
You may qualify if:
- Age \> 21 at time of screening.
- Patient will undergo a procedure utilizing an iFuse Implant family product.
- Patient is comfortable communicating in written and spoken English.
- Patient is willing and able to complete study questionnaires online, using either a smartphone, tablet, or computer.
- Patient is willing and able to provide informed consent to participate
You may not qualify if:
- Patient has fibromyalgia.
- Patient has a pain pump.
- Patient is currently receiving or seeking worker's compensation, disability remuneration, and/or involved in injury litigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SI-BONE, Inc.lead
Study Sites (1)
SI-BONE
Santa Clara, California, 94087, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Robyn Capobianco, PhD
SI-BONE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2024
First Posted
November 27, 2024
Study Start
December 15, 2024
Primary Completion (Estimated)
December 1, 2034
Study Completion (Estimated)
December 1, 2034
Last Updated
April 24, 2026
Record last verified: 2026-04